Table 3 Pigs vaccinated with E2 subunit vaccine developed high titers of anti-CSFV neutralizing antibodies
Treatment | Pig # | 35 DPV | 15 DPC | Treatment | Pig # | 35 DPV | 15 DPC |
|---|---|---|---|---|---|---|---|
(−/−) | 51 | 0 | 0 | (−/+) | 56 | 0 | >160 |
(−/−) | 52 | 0 | 0 | (−/+) | 57 | 0 | 0 |
(−/−) | 53 | 0 | 0 | (−/+) | 58 | 0 | 0 |
(−/−) | 54 | 0 | 0 | (−/+) | 59 | 0 | 0 |
(−/−) | 55 | 0 | 0 | (−/+) | 60 | 0 | 0 |
One-dose | 61 | 15 | 10,240 | Two-dose | 66 | 960 | 7680 |
One-dose | 62 | 240 | >10,240 | Two-dose | 67 | 640 | 7680 |
One-dose | 63 | 320 | >10,240 | Two-dose | 68 | 1920 | 10,240 |
One-dose | 64 | 20 | >10,240 | Two-dose | 69 | 7680 | 7680 |
One-dose | 65 | 640 | 5120 | Two-dose | 70 | 480 | 2560 |